Approval of Switch-OTC Epadel Puts Spotlight on Quality, Track Record of Pharmacists

A switch-OTC version of Mochida Pharmaceutical’s ethical hyperlipidemia treatment Epadel (ethyl icosapentate) is expected to be launched in the near future. It will be the first switch-OTC drug to be taken for long periods for a lifestyle disease. Once approved,...read more